Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$152.29

-3.27 (-2.10%)

16:22
08/08/17
08/08
16:22
08/08/17
16:22

Jazz backs FY17 adjusted EPS view of $10.70-$11.30, consensus $11.02

Backs FY17 revenue view of $1.625B-$1.7B, consensus $1.66B.

  • 08

    Aug

JAZZ Jazz Pharmaceuticals
$152.29

-3.27 (-2.10%)

06/07/17
JPMS
06/07/17
NO CHANGE
JPMS
Overweight
Jazz Pharmaceuticals data beat investor expectations, says JPMorgan
JPMorgan analyst Jessica Fye believes full results from the Phase III JZP-110 narcolepsy and obstructive sleep apnea studies established a "compelling clinical profile" and beat investor expectations. JZP-110 represents a long-term growth driver outside of Xyrem, Fye tells investors in a research note. She believes the current valuation does not fully the double-digit growth she expects Jazz to generate over the next several years. The analyst reiterates an Overweight rating on the shares.
06/07/17
COWN
06/07/17
NO CHANGE
Target $190
COWN
Outperform
Cowen tells investors to be involved now in Jazz Pharmaceuticals
Cowen analyst Ken Cacciatore noted Jazz Pharmaceuticals presented positive Phase lll data on its drug candidate to treat daytime sleepiness and said the results were as good as could be hoped for. Given its efficacy/safety profile, he believes JZP-110 is "best-in-class" and likely a $750M product and recommends investors get involved now. Cacciatore reiterated his Outperform rating and $190 price target on Jazz Pharmaceuticals shares.
08/03/17
BMOC
08/03/17
NO CHANGE
BMOC
Outperform
Vyxeos label an 'upside suprise' for Jazz, says BMO Capital
BMO Capital analyst Gary Nachman said the FDA approval of Jazz Pharmaceuticals' Vyxeos for "poor-prognosis" AML patients came "on the earlier side of expectations" and with the "upside surprise" that there are no age restrictions in the label indication. The analyst, who said he is still bullish on the prospects for Vyxeos, keeps an Outperform rating on Jazz shares.
08/08/17
COWN
08/08/17
NO CHANGE
Target $190
COWN
Outperform
Jazz Pharmaceuticals assets undervalued, says Cowen
Cowen analyst Ken Cacciatore said Jazz Pharmaceuticals provided input from clinical consultants and its own commentary on Vyxeos, which increased conviction in the drug. Cacciatore, who believes the totality of its assets are undervalued, reiterated his Outperform rating and $190 price target on Jazz shares.

TODAY'S FREE FLY STORIES

PCTY

Paylocity

$62.89

0.63 (1.01%)

14:59
12/10/18
12/10
14:59
12/10/18
14:59
Conference/Events
Paylocity management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

OMI

Owens & Minor

$7.14

0.18 (2.59%)

14:54
12/10/18
12/10
14:54
12/10/18
14:54
Hot Stocks
Owens & Minor names Joseph S. Pekala chief information officer »

Owens & Minor, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVIA

Covia

$4.81

-0.45 (-8.56%)

14:50
12/10/18
12/10
14:50
12/10/18
14:50
Hot Stocks
Breaking Hot Stocks news story on Covia »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFIX

Stitch Fix

$26.91

0.57 (2.16%)

14:49
12/10/18
12/10
14:49
12/10/18
14:49
Options
Stitch Fix options imply 30.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AIG

AIG

$37.12

-0.77 (-2.03%)

14:45
12/10/18
12/10
14:45
12/10/18
14:45
Options
AIG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GRO

Agria

$0.00

(0.00%)

14:43
12/10/18
12/10
14:43
12/10/18
14:43
Hot Stocks
Agria agrees to pay $3M to settle fraud charges »

The SEC announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVA

Covanta

$15.44

-0.18 (-1.15%)

14:41
12/10/18
12/10
14:41
12/10/18
14:41
Conference/Events
Covanta management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEX

Terex

$28.31

(0.00%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Conference/Events
Terex management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

, WCG

WellCare

$235.10

-3.8 (-1.59%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on T. Rowe Price, WellCare »

T. Rowe Price reports…

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

WCG

WellCare

$235.10

-3.8 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$1.30

-0.09 (-6.47%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on Stage Stores »

Axar Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
General news
Dow recovers loss of over 500 points, turns positive »

At time of writing, the…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTES

Gates Industrial

$13.98

0.02 (0.14%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
Conference/Events
Gates Industrial management to meet with UBS »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

14:35
12/10/18
12/10
14:35
12/10/18
14:35
General news
Treasury Action: yields have mostly edged up as Wall Street recovers »

Treasury Action: yields…

GD

General Dynamics

$170.66

3.28 (1.96%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Hot Stocks
General Dynamics awarded $346.5M contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

F

Ford

$8.49

-0.33 (-3.74%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Periodicals
Ford in talks with workers at German plant about job cuts, Reuters reports »

Ford confirmed that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

VLRX

Valeritas

$0.36

0.0296 (9.03%)

14:27
12/10/18
12/10
14:27
12/10/18
14:27
Hot Stocks
Breaking Hot Stocks news story on Valeritas »

Empery Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NIO

NIO Inc.

$6.90

-0.1 (-1.43%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETQ

PetIQ

$29.38

-2.08 (-6.61%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Conference/Events
PetIQ management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

KAI

Kadant

$80.36

-2.34 (-2.83%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Conference/Events
Kadant to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 20

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/10/18
12/10
14:17
12/10/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/10/18
12/10
14:16
12/10/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.67

1.07 (3.09%)

, P

Pandora

$8.63

-0.1 (-1.15%)

14:14
12/10/18
12/10
14:14
12/10/18
14:14
Recommendations
Yelp, Pandora, Web.com analyst commentary  »

Yelp could be worth…

YELP

Yelp

$35.67

1.07 (3.09%)

P

Pandora

$8.63

-0.1 (-1.15%)

WEB

Web.com

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BBT

BB&T

$46.94

-0.72 (-1.51%)

14:10
12/10/18
12/10
14:10
12/10/18
14:10
Options
4.5K Dec 44 - 46 put spreads trade 45c as BB&T shares drop 1.6% to $46.88 »

4.5K Dec 44 - 46 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Oct

DLTR

Dollar Tree

$83.55

0.155 (0.19%)

14:07
12/10/18
12/10
14:07
12/10/18
14:07
Conference/Events
Dollar Tree management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AGNC

AGNC Investment

$17.81

-0.01 (-0.06%)

14:05
12/10/18
12/10
14:05
12/10/18
14:05
Options
AGNC Investment Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.